![Hongming Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hongming Chen
Fondateur chez
METIS TECHBIO CO., LTD.
Fortune : 86 M $ au 31/07/2026
Profil
Hongming Chen was the founder of Kala Bio, Inc., founded in 2010, serving as Chief Scientific Officer.
Dr. Chen is the founder of METiS Therapeutics, Inc., founded in 2022, serving as President & Head-Research & Development.
Dr. Chen is the founder of Metis TechBio Co., Ltd., founded in 2020, serving as Director, Chief Research & Development Officer.
Dr. Chen is currently a Member at the National Academy of Engineering.
Former jobs include Director-Formulation Development at TransForm Pharmaceuticals, Inc. from 2000 to 2010, Senior Process Engineer at Merck & Co., Inc. in 1997, and Scientist at AstraZeneca PLC in 2000.
Education includes an undergraduate degree from The University of Texas at Austin in 1992, a graduate degree from Massachusetts Institute of Technology in 1995, and a doctorate from Massachusetts Institute of Technology in 1996.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/06/2026 | 46 839 443 ( 4,32 % ) | 60 M $ | 31/07/2026 | |
METIS TECHBIO CO., LTD. 20,16 % | 13/05/2026 | 20 074 047 ( 20,16 % ) | 26 M $ | 31/07/2026 |
Postes actifs de Hongming Chen
| Sociétés | Poste | Début |
|---|---|---|
| METIS TECHBIO CO., LTD. | Fondateur | 10/01/2020 |
National Academy of Engineering
 National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | - |
METiS Therapeutics, Inc.
 METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases | Fondateur | - |
Anciens postes connus de Hongming Chen
| Sociétés | Poste | Fin |
|---|---|---|
TransForm Pharmaceuticals, Inc.
 TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Corporate Officer/Principal | 01/01/2010 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2000 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/1997 |
| KALA BIO, INC. | Fondateur | - |
Formation de Hongming Chen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kala Bio, Inc.
 Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
National Academy of Engineering
National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
METiS Therapeutics, Inc.
METiS Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for patients with diseases | Health Technology |
Hangzhou Jitai Pharmaceutical Technology Co. Ltd.
 Hangzhou Jitai Pharmaceutical Technology Co. Ltd. Chemicals: Major DiversifiedProcess Industries Operates as an investment holding company whose subsidiaries provides AI based nanomaterials delivery and application services | Process Industries |
